615 related articles for article (PubMed ID: 16769916)
1. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
[TBL] [Abstract][Full Text] [Related]
3. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
Nissen SE
Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).
Nicholls SJ; Tuzcu EM; Schoenhagen P; Sipahi I; Crowe T; Kapadia S; Nissen SE
Am J Cardiol; 2005 Dec; 96(12):1636-9. PubMed ID: 16360349
[TBL] [Abstract][Full Text] [Related]
6. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
[TBL] [Abstract][Full Text] [Related]
7. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
10. Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Crowe T; Kapadia S; Nissen SE
Am Heart J; 2006 Sep; 152(3):544-50. PubMed ID: 16923429
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
[TBL] [Abstract][Full Text] [Related]
12. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study).
Nicholls SJ; Tuzcu EM; Sipahi I; Schoenhagen P; Hazen SL; Ntanios F; Wun CC; Nissen SE
Am J Cardiol; 2006 Jun; 97(11):1553-7. PubMed ID: 16728212
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.
Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Chen MS; Crowe T; Loyd AB; Kapadia S; Nissen SE
Atherosclerosis; 2006 Nov; 189(1):229-35. PubMed ID: 16427643
[TBL] [Abstract][Full Text] [Related]
14. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
Brener SJ; Ivanc TB; Hu T
J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
[TBL] [Abstract][Full Text] [Related]
15. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.
Eshtehardi P; McDaniel MC; Dhawan SS; Binongo JN; Krishnan SK; Golub L; Corban MT; Raggi P; Quyyumi AA; Samady H
J Invasive Cardiol; 2012 Oct; 24(10):522-9. PubMed ID: 23043036
[TBL] [Abstract][Full Text] [Related]
17. Effects of lipid-lowering therapy on coronary artery remodeling.
Schartl M; Bocksch W; Fateh-Moghadam S
Coron Artery Dis; 2004 Feb; 15(1):45-51. PubMed ID: 15201620
[TBL] [Abstract][Full Text] [Related]
18. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
19. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
[TBL] [Abstract][Full Text] [Related]
20. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
